To evaluate whether TMCG/DIPY treatment modified the methylation status of DNA in breast cancer cells by interfering with expression of the methyltransferase DNMT1, the expression levels of this gene were analysed by qRT-PCR (Fig. 3A). The gene discussed is DNMT1; the disease is breast carcinoma.